| Identification | Back Directory | [Name]
4-Acetylamino-5-Chloro-2-Hydroxybenzoic Acid Methyl Ester | [CAS]
24190-77-0 | [Synonyms]
4-Acetylamino-5-Chloro-2-
Methyl 4-acetamido-5-chlorosalicylate
4-acetylaMino-5-chloro-2-hydroxybenzoate
4-acetylamino-5-chloro-2-methoxybenzoate
Methyl 2-hydroxy-4-acetamido-5-chlorobenzoate
Methyl 5-chloro-4-acetaMido-2-hydroxybenzoate
methyl 4-acetamido-2-hydroxy-5-chlorobenzoate
Methyl 4-acetylaMino-5-chloro-2-hdroxybenzoate
METHYL 4-ACETYLAMINO-5-CHLORO-2-HYDROXYBENZOATE
4-Acetamido-5-chloro-2-hydroxybenzoic acid methyl ester
4-Acetylamino-5-Chloro-2-Hydroxybenzoic Acid Methyl Ester
Benzoicacid, 4-(acetylamino)-5-chloro-2-hydroxy-, methyl ester
Prucalopride Impurity 36Q: What is
Prucalopride Impurity 36 Q: What is the CAS Number of
Prucalopride Impurity 36 | [EINECS(EC#)]
246-857-6 | [Molecular Formula]
C10H10ClNO4 | [MDL Number]
MFCD02093078 | [MOL File]
24190-77-0.mol | [Molecular Weight]
243.64 |
| Chemical Properties | Back Directory | [Melting point ]
145-146℃ | [Boiling point ]
428.2±45.0 °C(Predicted) | [density ]
1.426 | [storage temp. ]
Sealed in dry,Room Temperature | [pka]
8.87±0.23(Predicted) | [Appearance]
White to off-white Solid |
| Hazard Information | Back Directory | [Synthesis]
Methyl 4-acetamido-2-hydroxybenzoate (61.4 g, 294.0 mmol) was dissolved with stirring in dichloroethane (1.2 L) followed by the addition of N-chlorosuccinimide (58.8 g, 441 mmol). The reaction mixture was heated to reflux for 3 hours. Upon completion of the reaction, the volatile solvent was removed by distillation under reduced pressure. Water (1.0 liter) was added to the residue to precipitate the solid product, which was collected by filtration. The crude product was dissolved in a solvent mixture of methanol and dichloromethane (1:9 v/v) and washed with saturated brine. The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure to afford methyl 4-acetamido-5-chloro-2-hydroxybenzoate (67.7 g) in 94.6% yield. The structure of the product was confirmed by nuclear magnetic resonance hydrogen spectroscopy (DMSO-d6): δ 10.49 (broad single peak, 1H), 9.47 (single peak, 1H), 7.75 (single peak, 1H), 7.72 (single peak, 1H), 3.85 (single peak, 3H), 2.16 (single peak, 3H); mass spectrometry analysis showed the molecular ion peaks (m/z) to be 244 and 246 (M+H)+. | [References]
[1] Patent: WO2013/42135, 2013, A1. Location in patent: Page/Page column 11
[2] Patent: US2014/187581, 2014, A1. Location in patent: Paragraph 0098-0100
[3] Patent: WO2016/128990, 2016, A1. Location in patent: Page/Page column 26-27
[4] Bioorganic and Medicinal Chemistry Letters, 1996, vol. 6, # 22, p. 2657 - 2662
[5] Patent: CN107337658, 2017, A. Location in patent: Paragraph 0043; 0044 |
|
|